Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2020 September;45(3) > Minerva Endocrinologica 2020 September;45(3):264-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2020 September;45(3):264-5

DOI: 10.23736/S0391-1977.20.03189-2

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Tolvaptan efficacy and drug-drug interactions

Matteo PICCICA 1, Gregorio BASILE 1, Filippo BARTALESI 2, Gabriele PARENTI 3, Alberto FARESE 2, Lisa BUCI 3, Giampaolo CORTI 1, 2, Alessandro BARTOLONI 1, 2, Alessandro PERI 4

1 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 2 Unit of Infectious and Tropical Diseases, Careggi University Hospital, Florence, Italy; 3 Unit of Pituitary Diseases and Sodium Alterations, Department of Endocrinology, Careggi University Hospital, Florence, Italy; 4 Pituitary Disease and Sodium Alterations Unit, Department of Endocrinology, University of Florence, AOU Careggi, Florence, Italy



top of page